191 related articles for article (PubMed ID: 25777618)
1. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
3. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
Padmanabhan A; Gosc EB; Bieberich CJ
J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.
Markowski MC; Bowen C; Gelmann EP
Cancer Res; 2008 Sep; 68(17):6896-901. PubMed ID: 18757402
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
[TBL] [Abstract][Full Text] [Related]
6. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Mediated Point Mutation in
Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
[No Abstract] [Full Text] [Related]
8. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
Rao V; Guan B; Mutton LN; Bieberich CJ
J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
[TBL] [Abstract][Full Text] [Related]
9. Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.
Padmanabhan A; Rao V; De Marzo AM; Bieberich CJ
Prostate; 2016 May; 76(6):523-33. PubMed ID: 26841725
[TBL] [Abstract][Full Text] [Related]
10. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
[TBL] [Abstract][Full Text] [Related]
11. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
[TBL] [Abstract][Full Text] [Related]
12. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
13. NKX3.1 activates cellular response to DNA damage.
Bowen C; Gelmann EP
Cancer Res; 2010 Apr; 70(8):3089-97. PubMed ID: 20395202
[TBL] [Abstract][Full Text] [Related]
14. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
[TBL] [Abstract][Full Text] [Related]
15. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
[TBL] [Abstract][Full Text] [Related]
17. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
18. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
19. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.
Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ
Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
